The FDA has also received 228 reports of EpiPen failures and at least 35 people were hospitalized as a result of those failures.
Defective EpiPens have been cited in seven deaths this year so far, according to reports made to the FDA and obtained by Bloomberg News.
During the same period, the FDA has received 228 reports of EpiPen failures and at least 35 people were hospitalized as a result of those failures.
Failure reports for Mylan’s (NSDQ:MYL) life-saving emergency allergy treatment have been growing in numbers over the past few years. In 2012, there four reports of device failures to the FDA. In the following year, there were 12 reports, according to Bloomberg News. And in 2014, that number jumped to 67.
